Successful treatment of prolonged COVID-19 with remdesivir and nirmatrelvir/ritonavir in a patient with a history of diffuse large B-cell lymphoma: a case report
Our case highlights the efficacy of administrating a combination treatment of remdesivir and nirmatrelvir/ritonavir outside recommended guidelines for the treatment of persistent COVID-19 infection in an immunocompromised individual. High-quality studies evaluating the usefulness of this combinatory therapy as a longer-course treatment in patients with neoplasms is warranted.
Authors
- Nancy Saulnier
- Nadia Bouhamdani (ORCID: https://orcid.org/0000-0002-0143-3487)
- Chantal S. Leger (ORCID: https://orcid.org/0000-0001-5807-3753)
- Dominique Comeau (ORCID: https://orcid.org/0000-0003-4879-4498)
- Josiane Stadler
Institutions
- Université de Sherbrooke (CA)
- Vitalité Health Network (CA)
Publication Details
- Journal
- Journal of the Egyptian National Cancer Institute
- Published
- 2025-06-29
- DOI
- https://doi.org/10.1186/s43046-025-00291-1
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.40